Home > Financial Ratios > AARTI DRUGS

AARTI DRUGS
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for AARTI DRUGS
Please provide your vote to see the results

AARTI DRUGS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Margin(%) 12.1512.1612.6911.3913.36

What is the latest Core EBITDA Margin ratio of AARTI DRUGS ?

The latest Core EBITDA Margin ratio of AARTI DRUGS is 12.15 based on Mar2026 Consolidated results.
Year Core EBITDA Margin
Mar202612.15
Mar202512.16
Mar202412.69
Mar202311.39
Mar202213.36

How is Core EBITDA Margin of AARTI DRUGS Trending?

Years Core EBITDA Margin % Change
Mar2026 12.15
-0.08
Mar2025 12.16
-4.18
Mar2024 12.69
11.41
Mar2023 11.39
-14.75
Mar2022 13.36 -

Other Financial Ratios of AARTI DRUGS


Compare Core EBITDA Margin ratio of peers of AARTI DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI DRUGS ₹3,789.0 Cr -1.7% -2.1% -14.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,483.0 Cr -3.2% -7.8% 9% Stock Analytics
DIVIS LABORATORIES ₹249,248.0 Cr 1% 0.9% 67.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,822.0 Cr -1.8% -4.8% 32.2% Stock Analytics
CIPLA ₹105,427.0 Cr -3.1% -6.5% -12.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,492.3 Cr -1.7% 3.1% -3.5% Stock Analytics


AARTI DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI DRUGS

-1.7%

-2.1%

-14.7%

SENSEX

-1.2%

-6.4%

-10.8%


You may also like the below Video Courses